Abstract

Objective: To assess the correlation between BDI II score as screening tools for early symptoms of depression with serum magnesium levels in regular hemodialysis patients. Methods: A cross-sectional study conducted on 48 patients with chronic kidney disease on regular HD in RSUP Haji Adam Malik. Patients included in this study were ≥ 18 years of age, on regular HD with a duration of ≥ 3 months, and were willing to be included in the study by signing a consent form after explanation. Patients with other psychiatric comorbidities other than depression and patients taking medicine that affect serum magnesium levels were excluded from the study. All studied patients were assessed for serum magnesium levels and depression symptoms using the BDI II questionnaire. Results: In this study we found that there is a significant correlation between serum Magnesium levels and BDI II score with a weak correlation strength level (r = - 0.35). The BDI II score in regular hemodialysis patients was found to be in a score of 4-15 with a median score of 7. Magnesium levels in regular hemodialysis patients ranged from 1.78 to 3.75 mg / dl, with a median of 2.9. Conclusions: In this study, there is a significant correlation found between serum Magnesium levels and BDI II score in patient on regular HD. Keywords: Beck Depression Inventory II (BD II) score, Chronic Kidney Disease, Hemodialysis, Serum magnesium levels.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call